ENSG ENSIGN GROUP, INC

Nasdaq Services-Skilled Nursing Care Facilities CIK: 0001125376
AI RATING
SELL
68% Confidence

Investment Thesis

Ensign Group demonstrates fundamental operational weakness with near-zero revenue growth (+0.5% YoY) and stagnant net income despite modest operating margins. Most critically, the 4.2% ROE is inadequate and indicates poor capital efficiency, with marginal free cash flow generation (2.1% FCF margin) suggesting the business is generating minimal shareholder value creation.

Strengths

  • + Fortress balance sheet with minimal leverage (0.06x Debt/Equity) and $539.5M cash position
  • + Exceptional interest coverage ratio of 63.6x indicating zero solvency risk
  • + EPS growth of 14.1% YoY demonstrates disciplined capital allocation through share buybacks

Risks

  • ! Revenue growth of only 0.5% YoY indicates a stagnant, mature business with no organic expansion
  • ! ROE of 4.2% and ROA of 1.8% are significantly below cost of capital, destroying shareholder value
  • ! Weak free cash flow generation ($28.6M FCF on $1.4B revenue = 2.1% margin) limits dividend capacity and growth investment

Key Metrics to Watch

Financial Metrics

Revenue
1.4B
Net Income
99.7M
EPS (Diluted)
$1.67
Free Cash Flow
28.6M
Total Assets
5.6B
Cash
539.5M

Profitability Ratios

Gross Margin N/A
Operating Margin 9.0%
Net Margin 7.2%
ROE 4.2%
ROA 1.8%
FCF Margin 2.1%

Balance Sheet & Liquidity

Current Ratio
1.56x
Quick Ratio
1.56x
Debt/Equity
0.06x
Debt/Assets
57.8%
Interest Coverage
63.57x
Long-term Debt
136.5M
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-05-06T17:32:39.044051 | Data as of: 2026-03-31 | Powered by Claude AI